HYUNDAI BIOLAND Statistics

Total Valuation

HYUNDAI BIOLAND has a market cap or net worth of KRW 143.70 billion. The enterprise value is 156.81 billion.

Market Cap	143.70B
Enterprise Value	156.81B

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

HYUNDAI BIOLAND has 30.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	30.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.70%
Float	19.50M

Valuation Ratios

The trailing PE ratio is 18.53 and the forward PE ratio is 8.45.

PE Ratio	18.53
Forward PE	8.45
PS Ratio	1.19
PB Ratio	0.99
P/TBV Ratio	1.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.72, with an EV/FCF ratio of -122.06.

EV / Earnings	20.21
EV / Sales	1.29
EV / EBITDA	8.72
EV / EBIT	13.72
EV / FCF	-122.06

Financial Position

The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.23.

Current Ratio	1.93
Quick Ratio	0.87
Debt / Equity	0.23
Debt / EBITDA	1.88
Debt / FCF	-26.26
Interest Coverage	7.41

Financial Efficiency

Return on equity (ROE) is 5.46% and return on invested capital (ROIC) is 4.06%.

Return on Equity (ROE)	5.46%
Return on Assets (ROA)	3.80%
Return on Invested Capital (ROIC)	4.06%
Return on Capital Employed (ROCE)	7.82%
Revenue Per Employee	378.65M
Profits Per Employee	24.24M
Employee Count	320
Asset Turnover	0.64
Inventory Turnover	1.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.37% in the last 52 weeks. The beta is 0.52, so HYUNDAI BIOLAND's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-51.37%
50-Day Moving Average	4,509.70
200-Day Moving Average	5,301.73
Relative Strength Index (RSI)	57.06
Average Volume (20 Days)	125,587

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HYUNDAI BIOLAND had revenue of KRW 121.17 billion and earned 7.76 billion in profits. Earnings per share was 258.54.

Revenue	121.17B
Gross Profit	48.09B
Operating Income	11.43B
Pretax Income	10.11B
Net Income	7.76B
EBITDA	17.99B
EBIT	11.43B
Earnings Per Share (EPS)	258.54

Full Income Statement

Balance Sheet

The company has 20.62 billion in cash and 33.73 billion in debt, giving a net cash position of -13.11 billion or -436.90 per share.

Cash & Cash Equivalents	20.62B
Total Debt	33.73B
Net Cash	-13.11B
Net Cash Per Share	-436.90
Equity (Book Value)	144.99B
Book Value Per Share	4,832.93
Working Capital	43.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.85 billion and capital expenditures -3.13 billion, giving a free cash flow of -1.28 billion.

Operating Cash Flow	1.85B
Capital Expenditures	-3.13B
Free Cash Flow	-1.28B
FCF Per Share	-42.82

Full Cash Flow Statement

Margins

Gross margin is 39.69%, with operating and profit margins of 9.44% and 6.40%.

Gross Margin	39.69%
Operating Margin	9.44%
Pretax Margin	8.35%
Profit Margin	6.40%
EBITDA Margin	14.85%
EBIT Margin	9.44%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.73%.

Dividend Per Share	35.00
Dividend Yield	0.73%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	1
Payout Ratio	13.54%
Buyback Yield	n/a
Shareholder Yield	0.73%
Earnings Yield	5.40%
FCF Yield	-0.89%

Dividend Details

Stock Splits

The last stock split was on May 17, 2024. It was a forward split with a ratio of 2.

Last Split Date	May 17, 2024
Split Type	Forward
Split Ratio	2

Scores

HYUNDAI BIOLAND has an Altman Z-Score of 3.85.

Altman Z-Score	3.85
Piotroski F-Score	n/a